Skip to main content
. 2025 Nov 27;489(3):575–581. doi: 10.1007/s00428-025-04363-4

Table 1.

Reported cases of MTOR-mutated RCC with concomitant loss of chromosome 1 in literature

Case Age/sex Size (cm) Stage PAX8 CD117 CK7 CK20 AE1/AE3 Melan A HMB45 Vimentin MTOR mutation Chr 1 Follow up (months)
1 (UChicago) 63/M 8.5 pT3aN1  +   +  -  + (focal) - - N/A - c.7279_7280delinsAA (p.L2427K) Loss Liver metastasis, 153 months alive
2 (UChicago) 55/M 12 pT3aNx  +   +  -  +  - - N/A -

c.4348_4368del

(p.Y1450_W1456del)

Loss Right rib metastasis and paracaval lymphadenopathy, 16 months alive
3 (Caliò et al.) 21/F 9.5 pT2aN1  +   + (focal) -  + (5%) - - - - c.4348_4368del (p.Y1450_W1456del) Loss Lymph node metastasis, 30 months alive
4 (Caliò et al.) 58/F 6.5 pT1bNx  +   + (focal) -  + (40%*) - - - - c.7280 T > A (p.L2427Q) Loss Skull metastasis after 132 months, 135 months alive
5 (Caliò et al.) 49/M 3.6 pT1aNx  +   + (focal) - - - - - - c.7280 T > A (p.L2427Q) Loss Liver metastasis after 36 months, 64 months alive

*Only positive in the skull metastasis